News & Updates
Filter by Specialty:
Show Multimedia Only

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients
02 Dec 2024
The overall utilization rates of SGLT2 inhibitors have increased among patients with type 2 diabetes (T2D) following the release of the 2022 American Diabetes Association (ADA) guidelines.